MedTrace Logo

Studies Examining the Importance of Smoking After Being Diagnosed With Lung Cancer

NCT01192256 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2400

Last updated 2022-08-04

No results posted yet for this study

Summary

A large project consisting of:

a) an observational trial where smoking status is recorded on 1400 consecutive people newly diagnosed with lung cancer. Smoking status is biologically validated with exhaled carbon monoxide (eCO) levels every 3 months. Survival, cancer progression and treatment complications will be recorded and compared in smokers, ex-smokers and never smokers.

Conditions

Sponsors & Collaborators

  • Cardiff and Vale University Health Board

    collaborator OTHER_GOV

  • Dr Keir Lewis

    lead OTHER

Principal Investigators

  • Keir E Lewis, MD · Hywel Dda

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2021-03-15
Completion
2021-03-15

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01192256 on ClinicalTrials.gov